Alazawi W - Search Results

1

Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16.

Alazawi W, Pett M, Arch B, Scott L, Freeman T, Stanley MA, Coleman N. Alazawi W, et al. Cancer Res. 2002 Dec 1;62(23):6959-65. Cancer Res. 2002. PMID: 12460913

2

Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes.

Pett MR, Alazawi WO, Roberts I, Dowen S, Smith DI, Stanley MA, Coleman N. Pett MR, et al. Cancer Res. 2004 Feb 15;64(4):1359-68. doi: 10.1158/0008-5472.can-03-3214. Cancer Res. 2004. PMID: 14973079

3

Interferon-beta treatment of cervical keratinocytes naturally infected with human papillomavirus 16 episomes promotes rapid reduction in episome numbers and emergence of latent integrants.

Herdman MT, Pett MR, Roberts I, Alazawi WO, Teschendorff AE, Zhang XY, Stanley MA, Coleman N. Herdman MT, et al. Carcinogenesis. 2006 Nov;27(11):2341-53. doi: 10.1093/carcin/bgl172. Epub 2006 Sep 14. Carcinogenesis. 2006. PMID: 16973673

4

Genomic imbalances in 70 snap-frozen cervical squamous intraepithelial lesions: associations with lesion grade, state of the HPV16 E2 gene and clinical outcome.

Alazawi W, Pett M, Strauss S, Moseley R, Gray J, Stanley M, Coleman N. Alazawi W, et al. Br J Cancer. 2004 Dec 13;91(12):2063-70. doi: 10.1038/sj.bjc.6602237. Br J Cancer. 2004. PMID: 15545968 Free PMC article.

5

Altered expression of desmosomal components in high-grade squamous intraepithelial lesions of the cervix.

Alazawi WO, Morris LS, Stanley MA, Garrod DR, Coleman N. Alazawi WO, et al. Virchows Arch. 2003 Jul;443(1):51-6. doi: 10.1007/s00428-003-0771-9. Epub 2003 May 21. Virchows Arch. 2003. PMID: 12759751

6

In vitro acid exposure has a differential effect on apoptotic and proliferative pathways in a Barrett's adenocarcinoma cell line.

Morgan C, Alazawi W, Sirieix P, Freeman T, Coleman N, Fitzgerald R. Morgan C, et al. Among authors: alazawi w. Am J Gastroenterol. 2004 Feb;99(2):218-24. doi: 10.1111/j.1572-0241.2004.04054.x. Am J Gastroenterol. 2004. PMID: 15046208

7

Primary or secondary malignancy? Fingerprint evidence.

Alazawi W, Gonzalez M, Abraham J, Arends M, Coleman N, Wilson C. Alazawi W, et al. Clin Oncol (R Coll Radiol). 2003 Oct;15(7):408-11. doi: 10.1016/s0936-6555(03)00062-1. Clin Oncol (R Coll Radiol). 2003. PMID: 14570089 No abstract available.

8

Advances in the diagnosis and treatment of hepatitis B.

Alazawi W, Foster GR. Alazawi W, et al. Curr Opin Infect Dis. 2008 Oct;21(5):508-15. doi: 10.1097/QCO.0b013e32830fb924. Curr Opin Infect Dis. 2008. PMID: 18725801 Review.

9

Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection.

Alazawi W, Cunningham M, Dearden J, Foster GR. Alazawi W, et al. Aliment Pharmacol Ther. 2010 Aug;32(3):344-55. doi: 10.1111/j.1365-2036.2010.04370.x. Epub 2010 May 22. Aliment Pharmacol Ther. 2010. PMID: 20497143 Review.

10

Pharmacology and therapeutic potential of interferons.

George PM, Badiger R, Alazawi W, Foster GR, Mitchell JA. George PM, et al. Among authors: alazawi w. Pharmacol Ther. 2012 Jul;135(1):44-53. doi: 10.1016/j.pharmthera.2012.03.006. Epub 2012 Mar 28. Pharmacol Ther. 2012. PMID: 22484806 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters